'Buprenorphine' presentation slideshows

Assessment and Treatment of Addictive Behaviors Carl W. Lejuez, PhD

Assessment and Treatment of Addictive Behaviors Carl W. Lejuez, PhD. Lecture 7 Drugs, Alcohol, and Smoking Treatment. Drug Treatment: Cost Effective?. Yes! Less expensive than alternatives, such as not treating addicts or simply incarcerating addicts

1.1k views • 80 slides

Assessment and Treatment of Addictive Behaviors Carl W. Lejuez, PhD

Assessment and Treatment of Addictive Behaviors Carl W. Lejuez, PhD. Lecture 6 Drug Treatment. Drug Treatment: Cost Effective?. Yes! Less expensive than alternatives, such as not treating addicts or simply incarcerating addicts 1 year of methadone maintenance is about $4,700 per patient

915 views • 80 slides

SUBSTANCE ABUSE & NEWBORNS

SUBSTANCE ABUSE & NEWBORNS. Why is this important:. 5.5% of pregnant women in the United States reported using at least one illicit drug during pregnancy. 21.2% of pregnant women aged 12-44 reported use of alcohol and 21.5% use of cigarettes during the past month. Drug Abuse in Pregnancy.

998 views • 63 slides

Expansion of M AT in Vermont: Minding the Crouching Dragons!

604 views • 53 slides

Buprenorphine: An Introduction

Buprenorphine: An Introduction. Walter Ling MD Integrated Substance Abuse Programs UCLA Los Angeles, CA April 21 st 2006 lwalter@ucla.edu www.uclaisap.org. Buprenorphine in the Treatment of Opioid Addiction. Buprenorphine as a medication Development: Historical perspective

633 views • 45 slides

Pharmacological Treatment of Addictive Disorders

Pharmacological Treatment of Addictive Disorders. Larissa Mooney, M.D. Assistant Professor of Psychiatry UCLA Integrated Substance Abuse Programs. Objectives. Introduction to medication treatment approaches for addictive disorders Pharmacological treatment options within drug classes:

808 views • 44 slides

ORAL SUBSTITUTION WITH BUPRENORPHINE Anju Dhawan Associate Professor

ORAL SUBSTITUTION WITH BUPRENORPHINE Anju Dhawan Associate Professor National Drug Dependence Treatment Centre AIIMS. Contents. History and Milestones Experience: Research and Clinical The Future. Contents. History and Milestones Our Experience: Clinical and Research The Future.

546 views • 44 slides

Assessment and Treatment of Addictive Behaviors Carl W. Lejuez, PhD

Assessment and Treatment of Addictive Behaviors Carl W. Lejuez, PhD. Lecture 9 Drug Treatment. Drug Treatment: Cost Effective?. Yes! Less expensive than alternatives, such as not treating addicts or simply incarcerating addicts 1 year of methadone maintenance is about $4,700 per patient

562 views • 41 slides

???? ?????? ?? ???? ???? ???? ?? ?????? ? ????????

Pharmacotherapy in Child and Adolescent Substance Abuse. ???? ?????? ?? ???? ???? ???? ?? ?????? ? ????????. ?????. ?????? ???? ?????? ?? ????? ??? 13 ?? 18 ??? ?? ??????: 1-1/6% ???? ??????? ???? ??: 4/5-10/5% ?? ???????? ??? ?? ????? ???? ?????? ???????? ???? ?? ?????? ? ????? ?????

524 views • 34 slides

Buprenorphine in the treatment of addiction

Buprenorphine in the treatment of addiction. Matthew A. Torrington MD Clinical Research Physician UCLA: Integrated Substance Abuse Programs Matrix Institute on Addictions Addiction Medicine Clinic November 4, 2004. Scope of this Talk.

708 views • 34 slides

Initiation of Buprenorphine in the Emergency Department

What is the evidence and how does it work?. Initiation of Buprenorphine in the Emergency Department. Continuing Education Credit: TEXT: 501-406-0076 Activity Code: 31374-24581. Teresa Hudson, PharmD , PhD. Disclosures.

527 views • 33 slides

Baltimore Buprenorphine Initiative

405 views • 26 slides

So You Prescribed Suboxone : Do Patients Really Take It?

So You Prescribed Suboxone : Do Patients Really Take It?. Discussion of Patient A dherence to Suboxone / Burprenorphine Regimens. Teresa Hudson, PharmD , PhD Associate Professor, Department of Psychiatry. CE Credits: TEXT: 501-406-0076 Activity Code: 29473-24581. NO Disclosures.

360 views • 25 slides

373 views • 24 slides

Buprenorphine and the NIDA CTN: Research to Practice

Buprenorphine and the NIDA CTN: Research to Practice. Walter Ling & Richard Rawson ISAP/UCLA XIII World Congress of Psychiatry September 14, 2005 Cairo, Egypt rrawson@mednet.ucla.edu www.uclaisap.org. Full agonist. -. Super agonist. -. fentanyl. morphine/heroin. hydromorphone.

331 views • 23 slides

UPDATE IN PAIN MEDICINE

UPDATE IN PAIN MEDICINE. RICHARD A. DuBOSE, M.D. DIRECTOR, IDAHO PAIN CENTER BOISE, IDAHO. OXYCONTIN. DEATHS w/ POLY ABUSE ER INCIDENCE 30% RX, 5% OPIATES ABUSE POTENTIAL LOW IF USED CORRECTLY COMPANY PROVIDES EDUCATION SPECIAL MARKINGS TO TELL WHERE MEDS COME FROM

306 views • 20 slides

Baltimore Buprenorphine Initiative Adam Brickner bSAS President/CEO January 3, 2008

Baltimore Buprenorphine Initiative Adam Brickner bSAS President/CEO January 3, 2008. Overview. System Structure Implementation Steps Lessons Learned. System Structure: Three Agency Collaborative Effort. Baltimore Substance Abuse Systems, Inc. Substance abuse treatment oversight

291 views • 17 slides

Department of Health & Wellness Promotion Bureau of Substance Abuse Prevention, Treatment & Recovery

275 views • 9 slides

Discontinuing Buprenorphine

283 views • 7 slides

State-level Influences on Buprenorphine Utilization: Variations in Opioid Addiction Treatment

State-level Influences on Buprenorphine Utilization: Variations in Opioid Addiction Treatment Lisa M. Lines, MPH and Robin E. Clark, PhD University of Massachusetts Medical School, Worcester, MA; lisa.lines@umassmed.edu

123 views • 1 slides